Cargando…
Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design
Prostate cancer is the second most diagnosed cancer in men and current treatment of advanced prostate cancer is ineffective. Immunotherapy has emerged as a promising treatment option for metastatic prostate cancer but its clinical application is still in the early stages of development. In order to...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721631/ https://www.ncbi.nlm.nih.gov/pubmed/26807308 http://dx.doi.org/10.4172/2155-9899.1000351 |